Gout is the most common cause of inflammatory arthritis and is becoming even more frequent with time. Up to one in 40 adults may experience gout. In order to manage gout correctly, it is very important to understand why it develops, how the treatments work and the correct way to take the medication prescribed by your doctor. It is also very helpful to make lifestyle adjustments when advised to do so to further help avoid painful attacks of gout 

To mark Gout Awareness Day, Wednesday 22nd May, Arthritis Ireland hosted a webinar with Professor Geraldine McCarthy to raise public awareness about this painful form of inflammatory arthritis.  

The webinar will cover:  

  1. Risk factors and diagnosis of gout. 

  1. Treating gout. 

  1. Lifestyle advice in relation to gout.  

  1. Possible consequences of untreated gout. 

About our speaker

Professor Geraldine McCarthy

Geraldine McCarthy MD, FRCPI Consultant Rheumatologist Mater Misericordiae University Hospital Dublin and Full Clinical Professor of Medicine University College Dublin, Ireland 


Geraldine McCarthy graduated in Medicine from University College Dublin, National University of Ireland. She received her Fellowship in Rheumatology at the Medical College of Wisconsin where she developed her interest in calcium crystal deposition diseases. Her research has focused on the biological effects of calcium-containing crystals in degenerative joint disease as well as in atherosclerosis and breast cancer and has been funded by many sources including the National Institutes of Health, Arthritis Foundation, American Federation for Aging Research, US Department of Defence, the Wellcome Trust and the Health Research Board. She was promoted to Associate Professor of Medicine at the Medical College of Wisconsin in 1996 where she remained until her return to Dublin, Ireland. 

She was appointed Consultant in Rheumatology at the Mater Misericordiae University Hospital and Cappagh National Orthopedic Hospital Dublin in 1999 where she continues to run a busy clinical practice and a clinical research program. She teaches as part of the University College Dublin Faculty of Medicine where she was the first clinician to be appointed Full Clinical Professor of Medicine through the Clinical Pathways in 2009. She has current international collaborations in the UK, USA, Europe, Australia, New Zealand and Canada, particularly in relation to calcium crystal deposition diseases as well as gout.  She continues her involvement in bench research related to the pathogenesis of basic calcium phosphate crystal–induced joint disease. She participates in and contributes to numerous international collaborations related to gout and calcium crystal deposition diseases. Other research interests include platelet activation in inflammatory arthritis and its role in enhanced cardiovascular risk. She also participates in collaborative studies of the pathogenesis of giant cell arteritis, HIV-associated bone pathology and osteoarthritis.

She is the author of over 170 publications, including original manuscripts, editorials, reviews and book chapters and has spoken at many national and international meetings. She has been winner of several research and teaching awards and has mentored many medicine and science graduates in clinical practice and in research. In 2021, she received the RCPI Institute of Medicine Bryan Alton Medal in recognition of her contribution to clinical and academic medicine. In 2022, she received a Lifetime Achievement award from G-CAN (Gout, Hyperuricemia and Crystal-Associated Disease Network). In 2023, she received designation of Master at the American College of Rheumatology Annual Scientific Meeting. She served as President of the Irish Society for Rheumatology for four years, from 2020 to 2023.